Inventor · disambiguated record
Martin Schaefer
Also filed as: SCHAEFER MARTIN · SCHAEFER MARTIN K · SCHAEFER MARTIN K H
10 granted patents·9 pending applications·15 citations·filing 2003–2024
83Inventor score
Top patents by PatentIndex Score
19 records- 0193US10815200B218F—tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancerDEUTSCHES KREBSFORSCH·Filed 2018·Granted Oct 27, 2020·8 cites·8 claims
- 0292US11913945B2Method for determining the amount of a therapeutic antibody in the brainHOFFMANN LA ROCHE·Filed 2020·Granted Feb 27, 2024·3 cites·14 claims
- 0383US12054458B218F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancerDEUTSCHES KREBSFORSCH·Filed 2023·Granted Aug 6, 2024·0 cites·12 claims
- 0482US11739142B2Bispecific anti-CCL2 antibodiesHOFFMANN LA ROCHE·Filed 2020·Granted Aug 29, 2023·1 cites·2 claims
- 0581US11020493B2Double-labeled probe for molecular imaging and use thereofDEUTSCHES KREBSFORSCH·Filed 2019·Granted Jun 1, 2021·1 cites·7 claims
- 0679US11452786B2Double-labeled probe for molecular imaging and use thereofDEUTSCHES KREBSFORSCH·Filed 2018·Granted Sep 27, 2022·1 cites·66 claims
- 0779US2024219381A1Method for determining the amount of a therapeutic antibody in the brainHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0877US12103967B2Bispecific anti-CCL2 antibodiesHOFFMANN LA ROCHE·Filed 2023·Granted Oct 1, 2024·0 cites·27 claims
- 0972US2022357340A1Method for determining the amount of a therapeutic antibody in the brainHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1072US2024083993A1Bispecific anti-ccl2 antibodiesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1171US10406246B2Double-labeled probe for molecular imaging and use thereofDEUTSCHES KREBSFORSCH·Filed 2014·Granted Sep 10, 2019·1 cites·11 claims
- 1268US12156920B2Double-labeled probe for molecular imaging and use thereofDEUTSCHES KREBSFORSCH·Filed 2022·Granted Dec 3, 2024·0 cites·22 claims
- 1368US2021053922A118f - tagged inhibitors of prostate specific membrane antigen (psma) and their use as imaging agents for prostate cancerDEUTSCHES KREBSFORSCH·Filed 2020·Application pending·0 cites
- 1456US2023393125A1Method for determining the free antigen of an antibody in a sampleHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1554US2004229217A1Screening process for various indications using BNPI and/or DNPIGRUENENTHAL GMBH·Filed 2004·Application pending·0 cites
- 1653US2004146942A1Screening method using PIM1-kinase or PIM3-kinaseGRUENENTHAL GMBH·Filed 2003·Application pending·0 cites
- 1745US11638765B2Double-labeled probe for molecular imaging and use thereofDEUTSCHES KREBSFORSCH·Filed 2018·Granted May 2, 2023·0 cites·41 claims
- 1843US2007117771A1VGLUT-specific dsRNA compoundsGRUENENTHAL GMBH·Filed 2006·Application pending·0 cites
- 1942US2006154886A1Regulatory elements in the 5' region of the VR1 geneGRUENENTHAL GMBH·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Schaefer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →